BMPR2 and pulmonary arterial hypertension: The loss of BMPR2 activity has been linked to increased toxicity in PAH [204,205], and aberrant hypermethylation of the BMPR2 promoter region has been reported in familial PAH patients [206], suggesting that DNA methylation may suppress BMPR2 gene expression.